Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Olam Cut to Sell by UBS on Concern Financial Health Worsens

Jan. 9 (Bloomberg) -- Olam International Ltd., the commodity trader targeted by short-seller Carson Block, was cut to sell from buy by UBS AG amid concern that the company’s financial health may be deteriorating.

UBS analysts Andreas Bokkenheuser and Anubhav Gupta reduced Olam’s 12-month target price by more than half to S$1.33 from S$2.95, they said in a report today. Shares of Olam, the world’s second-largest rice trader, fell as much as 1.6 percent before closing unchanged at S$1.605 in Singapore today.

UBS becomes the fifth brokerage to downgrade Olam since Block first questioned the company’s accounting methods at a London conference in November. He later rated it a “strong sell” in a report by his research firm Muddy Waters LLC and said the company may fail. Singapore-based Olam has refuted Block’s claims and said last week it’s in the best financial health since its 2005 initial share sale.

A bankruptcy analysis “suggests that Olam’s financial position has deteriorated to below financial health levels, although it remains above distress levels,” UBS’s Bokkenheuser and Gupta wrote in the report.

Olam’s earnings quality has deteriorated as the gap widens between earnings reported by Olam and earnings adjusted for items including changes in fair value of biological assets, negative goodwill, and government grants, according to UBS. Assumptions in determining fair value put earnings quality at risk, the analysts said.

Earnings Estimates

UBS cut its earnings-per-share estimate for Olam for 2013 by 45 percent, by 41 percent for 2014 and 44 percent for the year after, according to the report.

Olam said on Nov. 28 it faces no risk of insolvency. The company is “comfortable” with its debt, it said last week, adding that it had S$3.42 billion ($2.8 billion) of equity and S$6.99 billion of net debt as of Sept. 30. It had S$10.71 billion in cash, readily traded assets and undrawn credit lines as of that date, Olam said.

The commodity trader has provided answers to questions raised by UBS, Aditya Renjen, Olam’s general manager of investor relations, said today by phone from Singapore. The company “has been very clear” about Olam’s financial health, he said.

Rights Purchase

Olam said Dec. 3 it will offer $750 million in bonds and as much as $500 million in warrants. Temasek, Singapore’s state-owned investment company, said it would back Olam’s bond offering and will buy any rights not taken up by other investors. Michael Lim Choo San, a non-executive, independent director, invested in the rights offer, according to a regulatory statement today.

Borrowing costs are also an area of concern as the company may need to refinance its debts in the next two years, the UBS analysts said. Olam’s current covenants based on reported earnings are 4.5 times net debt-to-equity ratio, 1.5 times interest cover and S$1.2 billion minimum net worth, they said.

The stock lost 27 percent last year, making it the second-worst performer on Singapore’s benchmark Straits Times index. Ten analysts recommend buying Olam stock, 4 advise selling it and 6 rate it a hold, according to data compiled by Bloomberg.

To contact the reporter on this story: Michelle Yun in Hong Kong at myun11@bloomberg.net

To contact the editor responsible for this story: Jason Rogers at jrogers73@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.